ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global α-adrenoreceptor Antagonists Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-19O7076
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global α adrenoreceptor Antagonists Market Insights and Forecast to 2028
BUY CHAPTERS

Global α-adrenoreceptor Antagonists Market Research Report 2025

Code: QYRE-Auto-19O7076
Report
September 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical

α-adrenoreceptor Antagonists Market

The global market for α-adrenoreceptor Antagonists was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
α-adrenoreceptor antagonists are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).
North American market for α-adrenoreceptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for α-adrenoreceptor Antagonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of α-adrenoreceptor Antagonists include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for α-adrenoreceptor Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding α-adrenoreceptor Antagonists.
The α-adrenoreceptor Antagonists market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global α-adrenoreceptor Antagonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the α-adrenoreceptor Antagonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of α-adrenoreceptor Antagonists Market Report

Report Metric Details
Report Name α-adrenoreceptor Antagonists Market
Segment by Type
  • Non-selective Antagonists
  • Selective Antagonists
Segment by Application
  • Hypertension
  • Raynaud's Disease
  • Erectile Dysfunction
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of α-adrenoreceptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of α-adrenoreceptor Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the α-adrenoreceptor Antagonists Market report?

Ans: The main players in the α-adrenoreceptor Antagonists Market are Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical

What are the Application segmentation covered in the α-adrenoreceptor Antagonists Market report?

Ans: The Applications covered in the α-adrenoreceptor Antagonists Market report are Hypertension, Raynaud's Disease, Erectile Dysfunction

What are the Type segmentation covered in the α-adrenoreceptor Antagonists Market report?

Ans: The Types covered in the α-adrenoreceptor Antagonists Market report are Non-selective Antagonists, Selective Antagonists

1 α-adrenoreceptor Antagonists Market Overview
1.1 Product Definition
1.2 α-adrenoreceptor Antagonists by Type
1.2.1 Global α-adrenoreceptor Antagonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-selective Antagonists
1.2.3 Selective Antagonists
1.3 α-adrenoreceptor Antagonists by Application
1.3.1 Global α-adrenoreceptor Antagonists Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Raynaud's Disease
1.3.4 Erectile Dysfunction
1.4 Global α-adrenoreceptor Antagonists Market Size Estimates and Forecasts
1.4.1 Global α-adrenoreceptor Antagonists Revenue 2020-2031
1.4.2 Global α-adrenoreceptor Antagonists Sales 2020-2031
1.4.3 Global α-adrenoreceptor Antagonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 α-adrenoreceptor Antagonists Market Competition by Manufacturers
2.1 Global α-adrenoreceptor Antagonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global α-adrenoreceptor Antagonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global α-adrenoreceptor Antagonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of α-adrenoreceptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of α-adrenoreceptor Antagonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of α-adrenoreceptor Antagonists, Product Type & Application
2.7 Global Key Manufacturers of α-adrenoreceptor Antagonists, Date of Enter into This Industry
2.8 Global α-adrenoreceptor Antagonists Market Competitive Situation and Trends
2.8.1 Global α-adrenoreceptor Antagonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest α-adrenoreceptor Antagonists Players Market Share by Revenue
2.8.3 Global α-adrenoreceptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global α-adrenoreceptor Antagonists Market Scenario by Region
3.1 Global α-adrenoreceptor Antagonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global α-adrenoreceptor Antagonists Sales by Region: 2020-2031
3.2.1 Global α-adrenoreceptor Antagonists Sales by Region: 2020-2025
3.2.2 Global α-adrenoreceptor Antagonists Sales by Region: 2026-2031
3.3 Global α-adrenoreceptor Antagonists Revenue by Region: 2020-2031
3.3.1 Global α-adrenoreceptor Antagonists Revenue by Region: 2020-2025
3.3.2 Global α-adrenoreceptor Antagonists Revenue by Region: 2026-2031
3.4 North America α-adrenoreceptor Antagonists Market Facts & Figures by Country
3.4.1 North America α-adrenoreceptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America α-adrenoreceptor Antagonists Sales by Country (2020-2031)
3.4.3 North America α-adrenoreceptor Antagonists Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe α-adrenoreceptor Antagonists Market Facts & Figures by Country
3.5.1 Europe α-adrenoreceptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe α-adrenoreceptor Antagonists Sales by Country (2020-2031)
3.5.3 Europe α-adrenoreceptor Antagonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific α-adrenoreceptor Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific α-adrenoreceptor Antagonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific α-adrenoreceptor Antagonists Sales by Region (2020-2031)
3.6.3 Asia Pacific α-adrenoreceptor Antagonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America α-adrenoreceptor Antagonists Market Facts & Figures by Country
3.7.1 Latin America α-adrenoreceptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America α-adrenoreceptor Antagonists Sales by Country (2020-2031)
3.7.3 Latin America α-adrenoreceptor Antagonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa α-adrenoreceptor Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa α-adrenoreceptor Antagonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa α-adrenoreceptor Antagonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global α-adrenoreceptor Antagonists Sales by Type (2020-2031)
4.1.1 Global α-adrenoreceptor Antagonists Sales by Type (2020-2025)
4.1.2 Global α-adrenoreceptor Antagonists Sales by Type (2026-2031)
4.1.3 Global α-adrenoreceptor Antagonists Sales Market Share by Type (2020-2031)
4.2 Global α-adrenoreceptor Antagonists Revenue by Type (2020-2031)
4.2.1 Global α-adrenoreceptor Antagonists Revenue by Type (2020-2025)
4.2.2 Global α-adrenoreceptor Antagonists Revenue by Type (2026-2031)
4.2.3 Global α-adrenoreceptor Antagonists Revenue Market Share by Type (2020-2031)
4.3 Global α-adrenoreceptor Antagonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global α-adrenoreceptor Antagonists Sales by Application (2020-2031)
5.1.1 Global α-adrenoreceptor Antagonists Sales by Application (2020-2025)
5.1.2 Global α-adrenoreceptor Antagonists Sales by Application (2026-2031)
5.1.3 Global α-adrenoreceptor Antagonists Sales Market Share by Application (2020-2031)
5.2 Global α-adrenoreceptor Antagonists Revenue by Application (2020-2031)
5.2.1 Global α-adrenoreceptor Antagonists Revenue by Application (2020-2025)
5.2.2 Global α-adrenoreceptor Antagonists Revenue by Application (2026-2031)
5.2.3 Global α-adrenoreceptor Antagonists Revenue Market Share by Application (2020-2031)
5.3 Global α-adrenoreceptor Antagonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer α-adrenoreceptor Antagonists Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis α-adrenoreceptor Antagonists Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck α-adrenoreceptor Antagonists Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Company Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astra Zeneca α-adrenoreceptor Antagonists Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Company Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jhonson and Johnson α-adrenoreceptor Antagonists Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly α-adrenoreceptor Antagonists Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi α-adrenoreceptor Antagonists Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb α-adrenoreceptor Antagonists Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer α-adrenoreceptor Antagonists Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK α-adrenoreceptor Antagonists Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Company Information
6.11.2 Teva Pharmaceutical Description and Business Overview
6.11.3 Teva Pharmaceutical α-adrenoreceptor Antagonists Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceutical α-adrenoreceptor Antagonists Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 α-adrenoreceptor Antagonists Industry Chain Analysis
7.2 α-adrenoreceptor Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 α-adrenoreceptor Antagonists Production Mode & Process Analysis
7.4 α-adrenoreceptor Antagonists Sales and Marketing
7.4.1 α-adrenoreceptor Antagonists Sales Channels
7.4.2 α-adrenoreceptor Antagonists Distributors
7.5 α-adrenoreceptor Antagonists Customer Analysis
8 α-adrenoreceptor Antagonists Market Dynamics
8.1 α-adrenoreceptor Antagonists Industry Trends
8.2 α-adrenoreceptor Antagonists Market Drivers
8.3 α-adrenoreceptor Antagonists Market Challenges
8.4 α-adrenoreceptor Antagonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical
List of Tables
 Table 1. Global α-adrenoreceptor Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global α-adrenoreceptor Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global α-adrenoreceptor Antagonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global α-adrenoreceptor Antagonists Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global α-adrenoreceptor Antagonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global α-adrenoreceptor Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global α-adrenoreceptor Antagonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market α-adrenoreceptor Antagonists Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of α-adrenoreceptor Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of α-adrenoreceptor Antagonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of α-adrenoreceptor Antagonists, Product Type & Application
 Table 12. Global Key Manufacturers of α-adrenoreceptor Antagonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global α-adrenoreceptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in α-adrenoreceptor Antagonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global α-adrenoreceptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global α-adrenoreceptor Antagonists Sales by Region (2020-2025) & (K MT)
 Table 18. Global α-adrenoreceptor Antagonists Sales Market Share by Region (2020-2025)
 Table 19. Global α-adrenoreceptor Antagonists Sales by Region (2026-2031) & (K MT)
 Table 20. Global α-adrenoreceptor Antagonists Sales Market Share by Region (2026-2031)
 Table 21. Global α-adrenoreceptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global α-adrenoreceptor Antagonists Revenue Market Share by Region (2020-2025)
 Table 23. Global α-adrenoreceptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global α-adrenoreceptor Antagonists Revenue Market Share by Region (2026-2031)
 Table 25. North America α-adrenoreceptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America α-adrenoreceptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 27. North America α-adrenoreceptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 28. North America α-adrenoreceptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America α-adrenoreceptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe α-adrenoreceptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe α-adrenoreceptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 32. Europe α-adrenoreceptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 33. Europe α-adrenoreceptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe α-adrenoreceptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific α-adrenoreceptor Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific α-adrenoreceptor Antagonists Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific α-adrenoreceptor Antagonists Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific α-adrenoreceptor Antagonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific α-adrenoreceptor Antagonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America α-adrenoreceptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America α-adrenoreceptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America α-adrenoreceptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America α-adrenoreceptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America α-adrenoreceptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa α-adrenoreceptor Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa α-adrenoreceptor Antagonists Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa α-adrenoreceptor Antagonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa α-adrenoreceptor Antagonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global α-adrenoreceptor Antagonists Sales (K MT) by Type (2020-2025)
 Table 51. Global α-adrenoreceptor Antagonists Sales (K MT) by Type (2026-2031)
 Table 52. Global α-adrenoreceptor Antagonists Sales Market Share by Type (2020-2025)
 Table 53. Global α-adrenoreceptor Antagonists Sales Market Share by Type (2026-2031)
 Table 54. Global α-adrenoreceptor Antagonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global α-adrenoreceptor Antagonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global α-adrenoreceptor Antagonists Revenue Market Share by Type (2020-2025)
 Table 57. Global α-adrenoreceptor Antagonists Revenue Market Share by Type (2026-2031)
 Table 58. Global α-adrenoreceptor Antagonists Price (USD/MT) by Type (2020-2025)
 Table 59. Global α-adrenoreceptor Antagonists Price (USD/MT) by Type (2026-2031)
 Table 60. Global α-adrenoreceptor Antagonists Sales (K MT) by Application (2020-2025)
 Table 61. Global α-adrenoreceptor Antagonists Sales (K MT) by Application (2026-2031)
 Table 62. Global α-adrenoreceptor Antagonists Sales Market Share by Application (2020-2025)
 Table 63. Global α-adrenoreceptor Antagonists Sales Market Share by Application (2026-2031)
 Table 64. Global α-adrenoreceptor Antagonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global α-adrenoreceptor Antagonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global α-adrenoreceptor Antagonists Revenue Market Share by Application (2020-2025)
 Table 67. Global α-adrenoreceptor Antagonists Revenue Market Share by Application (2026-2031)
 Table 68. Global α-adrenoreceptor Antagonists Price (USD/MT) by Application (2020-2025)
 Table 69. Global α-adrenoreceptor Antagonists Price (USD/MT) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Pfizer α-adrenoreceptor Antagonists Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Novartis α-adrenoreceptor Antagonists Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Merck α-adrenoreceptor Antagonists Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Astra Zeneca Company Information
 Table 86. Astra Zeneca Description and Business Overview
 Table 87. Astra Zeneca α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Astra Zeneca α-adrenoreceptor Antagonists Product
 Table 89. Astra Zeneca Recent Developments/Updates
 Table 90. Jhonson and Johnson Company Information
 Table 91. Jhonson and Johnson Description and Business Overview
 Table 92. Jhonson and Johnson α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Jhonson and Johnson α-adrenoreceptor Antagonists Product
 Table 94. Jhonson and Johnson Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Eli Lilly α-adrenoreceptor Antagonists Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Sanofi α-adrenoreceptor Antagonists Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb α-adrenoreceptor Antagonists Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Bayer α-adrenoreceptor Antagonists Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. GSK α-adrenoreceptor Antagonists Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Teva Pharmaceutical Company Information
 Table 121. Teva Pharmaceutical Description and Business Overview
 Table 122. Teva Pharmaceutical α-adrenoreceptor Antagonists Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceutical α-adrenoreceptor Antagonists Product
 Table 124. Teva Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. α-adrenoreceptor Antagonists Distributors List
 Table 128. α-adrenoreceptor Antagonists Customers List
 Table 129. α-adrenoreceptor Antagonists Market Trends
 Table 130. α-adrenoreceptor Antagonists Market Drivers
 Table 131. α-adrenoreceptor Antagonists Market Challenges
 Table 132. α-adrenoreceptor Antagonists Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of α-adrenoreceptor Antagonists
 Figure 2. Global α-adrenoreceptor Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global α-adrenoreceptor Antagonists Market Share by Type: 2024 & 2031
 Figure 4. Non-selective Antagonists Product Picture
 Figure 5. Selective Antagonists Product Picture
 Figure 6. Global α-adrenoreceptor Antagonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global α-adrenoreceptor Antagonists Market Share by Application: 2024 & 2031
 Figure 8. Hypertension
 Figure 9. Raynaud's Disease
 Figure 10. Erectile Dysfunction
 Figure 11. Global α-adrenoreceptor Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global α-adrenoreceptor Antagonists Market Size (2020-2031) & (US$ Million)
 Figure 13. Global α-adrenoreceptor Antagonists Sales (2020-2031) & (K MT)
 Figure 14. Global α-adrenoreceptor Antagonists Average Price (USD/MT) & (2020-2031)
 Figure 15. α-adrenoreceptor Antagonists Report Years Considered
 Figure 16. α-adrenoreceptor Antagonists Sales Share by Manufacturers in 2024
 Figure 17. Global α-adrenoreceptor Antagonists Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest α-adrenoreceptor Antagonists Players: Market Share by Revenue in α-adrenoreceptor Antagonists in 2024
 Figure 19. α-adrenoreceptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global α-adrenoreceptor Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America α-adrenoreceptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 22. North America α-adrenoreceptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe α-adrenoreceptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 26. Europe α-adrenoreceptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 27. Germany α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific α-adrenoreceptor Antagonists Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific α-adrenoreceptor Antagonists Revenue Market Share by Region (2020-2031)
 Figure 34. China α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America α-adrenoreceptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 45. Latin America α-adrenoreceptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa α-adrenoreceptor Antagonists Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E α-adrenoreceptor Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of α-adrenoreceptor Antagonists by Type (2020-2031)
 Figure 55. Global Revenue Market Share of α-adrenoreceptor Antagonists by Type (2020-2031)
 Figure 56. Global α-adrenoreceptor Antagonists Price (USD/MT) by Type (2020-2031)
 Figure 57. Global Sales Market Share of α-adrenoreceptor Antagonists by Application (2020-2031)
 Figure 58. Global Revenue Market Share of α-adrenoreceptor Antagonists by Application (2020-2031)
 Figure 59. Global α-adrenoreceptor Antagonists Price (USD/MT) by Application (2020-2031)
 Figure 60. α-adrenoreceptor Antagonists Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global α blocker Market Research Report 2024
Global Alpha Blockers Market Research Report 2024
Global α Adrenergic Agonist Market Research Report 2024
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Beta Blockers Market Research Report 2025
Global Anti Adrenergic Agent Market Research Report 2024
Adrenoceptor Blocking Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adrenergic Agonist Market Research Report 2024
Global 5 HT Receptor Antagonist Market Research Report 2025
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global AT1 Receptor Antagonists Market Research Report 2024
Global Melanocortin Receptor Agonist Drugs Market Research Report 2024
Global Doxazosin Mesylate Market Research Report 2024
Global Alpha receptor Antagonists Market Research Report 2024
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Purinergic Receptor Antagonists Market Research Report 2024
Global Neurokinin Receptor Antagonists Market Research Report 2024
Global Antihypertensive Drugs Market Research Report 2024
Global Dopamine Receptor Agonists Market Research Report 2025
Endothelin Antagonists Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions